NHS National Framework Agreement for Adalimumab Injection
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Buyer
NHS England
Value
£445,000,000
Published
21 May 2020
Closes
17 Feb 2020
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
31 Mar 2020
Contract ends
31 Mar 2022
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Framework Agreement for Adalimumab Injection
£125,000,000
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, London · United Kingdom, North East · United Kingdom, North West · United Kingdom, South East · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
15 Jan 2020
Opportunity notice on Contracts Finder
Tender notice · Web page
Link to eSourcing Portal
Not provided
Link to eSourcing Portal
Tender notice
Awarded contract notice on Contracts Finder
21 May 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
Contains public sector information licensed under the Open Government Licence v3.0.